发明授权
US07470429B2 Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug 有权
用于增加化疗药物靶标特异性毒性的方法和组合物

  • 专利标题: Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
  • 专利标题(中): 用于增加化疗药物靶标特异性毒性的方法和组合物
  • 申请号: US10066782
    申请日: 2002-02-06
  • 公开(公告)号: US07470429B2
    公开(公告)日: 2008-12-30
  • 发明人: Gary L. GriffithsHans J. Hansen
  • 申请人: Gary L. GriffithsHans J. Hansen
  • 申请人地址: US NJ Morris Plains
  • 专利权人: Immunomedics, Inc.
  • 当前专利权人: Immunomedics, Inc.
  • 当前专利权人地址: US NJ Morris Plains
  • 代理商 Richard A. Nakashima
  • 主分类号: A61K39/00
  • IPC分类号: A61K39/00
Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
摘要:
A method for increasing the target-specific toxicity of a drug is effected by pretargeting an enzyme to a mammalian target site, and then administering a cytotoxic drug known to act at the target site, or a prodrug form thereof which is converted to the drug in situ, which drug is also detoxified to form an intermediate of lower toxicity using said mammal's ordinary metabolic processes, whereby the detoxified intermediate is reconverted to its more toxic form by the pretargeted enzyme and thus has enhanced cytotoxicity at the target site. Further enhancement can be achieved by pretargeting an enzyme which converts the prodrug to the cytotoxic drug at the target site. Kits for use with the method also are provided. The method and kits permit lower doses of cytotoxic agents, maximize target site activity and minimize systemic side effects.
信息查询
0/0